About
Genprex Inc (NASDAQ:GNPX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meeting
Apr 21 2026
Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy
Apr 20 2026
Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
Mar 18 2026
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
Mar 10 2026
Genprex to Participate at BIO Europe Spring 2026
Financials
Revenue
$0
Market Cap
$3.36 M
EPS
-17.40
Google Übersetzer